The Role of IL-6 in Inflammatory Diseases CME/CE
Bernard Rubin, DO, MPH; Gary S. Firestein, MD; Leonard H. Calabrese, DO
www.medscape.com

This program will provide clinicians with a basic understanding of the role of interleukin-6 (IL-6) in the pathogenesis of inflammatory disease with a particular focus on its actions in the initiation, ongoing joint damage, and systemic manifestations associated with rheumatoid arthritis (RA). A description of how IL-6 participates in the inflammatory cascade will be provided and the importance of both the membrane-bound and soluble IL-6 receptor for targeting cells will be emphasized. Preliminary clinical data from trials of a humanized monoclonal antibody directed against the IL-6 receptor in patients with RA will be presented and the efficacy and safety of this approach to the treatment of RA evaluated.

Participants have the opportunity to view this roundtable discussion in a slides & video format.

http://www.medscape.com/viewprogram/7135?sssdmh=dm1.276511&src=nlcmealert